drugset

drugset / Trial / NCT06715670

A Study to Investigate the Blood Concentrations of 4 Different Oral Doses of Zibotentan in Healthy Non-Asian and Japanese Participants

NCT06715670 ↗

Phase 1 Completed 30 enrolled AstraZeneca Parexel · collab

RandomizedCrossoverOpen-labelTreatment

Summary

This study aim to assess the Pharmacokinetics of Zibotentan in Healthy Non-Asian and Japanese Participants.

Timeline

Start: 2024-12-05
Primary completion: 2025-02-28
Completion: 2025-02-28

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Zibotentan	Small molecule	—	Oral

Indications